UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Dopamine receptor type 2 (DRD2) inhibits migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivation

Cancer letters, 2016-10, Vol.381 (2), p.279-286

2016

Volltextzugriff (PDF)

cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells

Cancer letters, 2018-10, Vol.435, p.101-109

2018

Volltextzugriff (PDF)

Cyclic adenosine 3′-5′-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac)

Molecular and cellular endocrinology, 2014-03, Vol.383 (1-2), p.193-202

2014

Volltextzugriff (PDF)

Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem‐like cells isolated from nonfunctioning pituitary tumors

International journal of cancer, 2017-04, Vol.140 (8), p.1870-1880

2017

Volltextzugriff (PDF)

Cytoskeleton actin-binding proteins in clinical behavior of pituitary tumors

Endocrine-related cancer, 2019-02, Vol.26 (2), p.R95-R108

2019

Volltextzugriff (PDF)

A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment

International journal of cancer, 2018-05, Vol.142 (9), p.1842-1852

2018

Volltextzugriff (PDF)

Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion

Molecular and cellular endocrinology, 2021-01, Vol.520, p.111092-111092, Article 111092

2021

Volltextzugriff (PDF)

The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells

Cancer letters, 2021-01, Vol.497, p.77-88

2021

Volltextzugriff (PDF)

Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation

Molecular and cellular endocrinology, 2019-09, Vol.495, p.110519-110519, Article 110519

2019

Volltextzugriff (PDF)

Filamin A (FLNA) Plays an Essential Role in Somatostatin Receptor 2 (SST2) Signaling and Stabilization After Agonist Stimulation in Human and Rat Somatotroph Tumor Cells

Endocrinology (Philadelphia), 2014-08, Vol.155 (8), p.2932-2941

2014

Volltextzugriff (PDF)

Novel insights to study the potential of the somatostatin system in NETs and NECs

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2022-11, Vol.22, p.e73-e73

2022

Volltextzugriff (PDF)

Somatostatin Receptor Type 2 (SSTR2) Internalization and Intracellular Trafficking in Pituitary GH-Secreting Adenomas: Role of Scaffold Proteins and Implications for Pharmacological Resistance

Hormone and metabolic research, 2017-04, Vol.49 (4), p.259

2017

Volltextzugriff (PDF)

Macroautophagy and the proteasome are differently involved in the degradation of alpha-synuclein wild type and mutated A30P in an in vitro inducible model (PC12/TetOn)

Neuroscience, 2011-11, Vol.195 (4), p.128-137

2011

Volltextzugriff (PDF)

Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation

Hormone and metabolic research, 2014-11, Vol.46 (12), p.845

2014

Volltextzugriff (PDF)

cAMP effects in neuroendocrine tumors: The role of Epac and PKA in cell proliferation and adhesion

Experimental cell research, 2015-12, Vol.339 (2), p.241-251

2015

Volltextzugriff (PDF)

Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells

Cancer letters, 2017-10, Vol.406, p.54-63

2017

Volltextzugriff (PDF)

Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2

Endocrine-related cancer, 2006-09, Vol.13 (3), p.955-962

2006

Volltextzugriff (PDF)

High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells

Oncogene, 2008-03, Vol.27 (13), p.1834-1843

2008

Volltextzugriff (PDF)

Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: effect of glycemic control and visceral adiposity on Leydig cell function

European journal of endocrinology, 2009-12, Vol.161 (6), p.853

2009

Volltextzugriff (PDF)

Different expression of protein kinase A (PKA) regulatory subunits in cortisol-secreting adrenocortical tumors: Relationship with cell proliferation

Experimental cell research, 2008, Vol.314 (1), p.123-130

2008

Volltextzugriff (PDF)

Analysis of genetic variants of phosphodiesterase 11A in acromegalic patients

European journal of endocrinology, 2009-11, Vol.161 (5), p.687

2009

Volltextzugriff (PDF)

Effect of Cyclic Adenosine 3′,5′-Monophosphate/Protein Kinase A Pathway on Markers of Cell Proliferation in Nonfunctioning Pituitary Adenomas

The journal of clinical endocrinology and metabolism, 2005-12, Vol.90 (12), p.6721-6724

2005

Volltextzugriff (PDF)

Analysis of GNAS1 and PRKAR1A gene mutations in human cardiac myxomas not associated with multiple endocrine disorders

Journal of endocrinological investigation, 2009-06, Vol.32 (6), p.501-504

2009

Volltextzugriff (PDF)

Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations

Endocrine-related cancer, 2013-10, Vol.20 (5), p.753-766

2013

Volltextzugriff (PDF)

HESX1 expression in human normal pituitaries and pituitary adenomas

Molecular and cellular endocrinology, 2006-03, Vol.247 (1), p.135-139

2006

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Aktive Filter

SprachePortugiesisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(64)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dopamine receptor type 2 (DRD2) inhibits migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivation

cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells

Cyclic adenosine 3′-5′-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac)

Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem‐like cells isolated from nonfunctioning pituitary tumors

Cytoskeleton actin-binding proteins in clinical behavior of pituitary tumors

A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment

Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion

The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells

Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation

Filamin A (FLNA) Plays an Essential Role in Somatostatin Receptor 2 (SST2) Signaling and Stabilization After Agonist Stimulation in Human and Rat Somatotroph Tumor Cells

Novel insights to study the potential of the somatostatin system in NETs and NECs

Somatostatin Receptor Type 2 (SSTR2) Internalization and Intracellular Trafficking in Pituitary GH-Secreting Adenomas: Role of Scaffold Proteins and Implications for Pharmacological Resistance

Macroautophagy and the proteasome are differently involved in the degradation of alpha-synuclein wild type and mutated A30P in an in vitro inducible model (PC12/TetOn)

Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation

cAMP effects in neuroendocrine tumors: The role of Epac and PKA in cell proliferation and adhesion

Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells

Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2

High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells

Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: effect of glycemic control and visceral adiposity on Leydig cell function

Different expression of protein kinase A (PKA) regulatory subunits in cortisol-secreting adrenocortical tumors: Relationship with cell proliferation

Analysis of genetic variants of phosphodiesterase 11A in acromegalic patients

Effect of Cyclic Adenosine 3′,5′-Monophosphate/Protein Kinase A Pathway on Markers of Cell Proliferation in Nonfunctioning Pituitary Adenomas

Analysis of GNAS1 and PRKAR1A gene mutations in human cardiac myxomas not associated with multiple endocrine disorders

Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations

HESX1 expression in human normal pituitaries and pituitary adenomas

Aktive Filter

Suchergebnisse filtern